GlassScriptPhysician profile
Usman Baber
NPI 1538378427
$76,368.73
in general payments reported to CMS, 2019-2025
35 companies · $6,752 in 2025
The $6,752 reported for 2025 was more than what 86% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $12K · 2021: $7,623 · 2022: $18K · 2023: $11K · 2024: $8,874 · 2025: $6,752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,500 · Food and Beverage: $5,217 · Travel and Lodging: $2,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,735.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,500.00 |
| Food and Beverage | $5,217.12 |
| Travel and Lodging | $2,315.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $37,296.29 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $15,155.23 | 2019-2024 | Brilinta |
| Boston Scientific Corporation | $13,130.01 | 2019-2025 | General - Vascular Access, Watchman Flx, General - Balloon Catheters |
| Abbott Laboratories | $4,208.45 | 2020-2025 | Dragonfly Opstar, Perclose Prostyle |
| Abiomed | $2,424.49 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $588.35 | 2020-2025 | Evoque |
| Inari Medical, INC. | $473.46 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $333.51 | 2019-2025 | Lifevest |
| Chiesi USA, INC. | $285.67 | 2019-2023 | Cleviprex, Kengreal |
| Medtronic, INC. | $261.41 | 2023-2024 | Corevalve Evolut R, Hawkone, In.Pact Av |
| Shockwave Medical, INC | $192.90 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic Vascular, INC. | $179.80 | 2019 | |
| Merck Sharp & Dohme LLC | $165.39 | 2022-2025 | Winrevair |
| Stryker Corporation | $161.79 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pulmonx Corporation | $156.99 | 2024-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $142.71 | 2023-2025 | Camzyos, Eliquis |
| Philips North America LLC | $141.89 | 2019 | |
| Penumbra, INC. | $138.41 | 2022 | |
| Novartis Pharmaceuticals Corporation | $124.79 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $122.97 | 2020-2023 | Xarelto |
| Teleflex LLC | $120.17 | 2025 | Guideliner |
| Baxter Healthcare | $96.82 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Irhythm Technologies, INC. | $68.35 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Janssen Scientific Affairs, LLC | $65.89 | 2019 | |
| Cardiovascular Systems INC. | $64.13 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $62.54 | 2022-2023 | Opsumit |
| Pfizer INC. | $51.79 | 2025 | |
| Terumo Medical Corporation | $27.96 | 2023 | Angio-Seal |
| Cardiva Medical, INC. | $23.23 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.19 | 2024 | Jardiance |
| W. L. Gore & Associates, INC. | $18.93 | 2024 | Gore Cardioform Septal Occluder |
| Insmed, INC. | $18.00 | 2025 | Arikayce |
| Ani Pharmaceuticals, INC. | $16.03 | 2025 | Purified Cortrophin Gel |
| Asahi Intecc USA, INC. | $15.36 | 2022 | |
| Bardy Diagnostics, INC. | $14.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Usman Baber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.